Article Details
Retrieved on: 2022-08-19 11:00:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The drugs - Regeneron's Inmazeb (REGN-EB3) and Ridgeback Bio's Ebanga (mAb114) - use laboratory-made monoclonal antibodies that mimic natural ...
Article found on: www.dtnext.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here